HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Hontsa Selected Research

Neoplasms (Cancer)

7/2014A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Hontsa Research Topics

Disease

1Adenocarcinoma
09/2017
1Stomach Neoplasms (Stomach Cancer)
09/2017
1Vomiting
07/2014
1Nausea
07/2014
1Neoplasms (Cancer)
07/2014

Drug/Important Bio-Agent (IBA)

1Fluorouracil (Carac)FDA LinkGeneric
09/2017
1Cisplatin (Platino)FDA LinkGeneric
09/2017
1netupitantIBA
07/2014
1Palonosetron (Aloxi)FDA Link
07/2014
1AntiemeticsIBA
07/2014

Therapy/Procedure

2Drug Therapy (Chemotherapy)
09/2017 - 07/2014